PROMOTED CONTENT
Dr Yohana Mokiwa with a patient, Dar es Salaam, Tanzania
The Catalyst Effect: Unlocking innovation for global NCD care through cross-sector collaboration Noncommunicable diseases are the silent crisis of our time – devastating lives and economies across developing regions. Yet the global response remains fragmented, underfunded, and overdue for reinvention
N oncommunicable diseases (NCDs) - including diabetes, cardiovascular disease, cancer, and chronic respiratory conditions - account for the majority of global deaths. In 2021 alone, they claimed more than 43 million lives – three-quarters of all non-pandemic- related deaths globally. Of these, 18 million were premature deaths occurring before the age of 70, with 82% of them in low- and middle-income countries (LMICs). Today, we are at a critical inflection point in addressing this growing challenge. NCDs are projected to cost LMICs $7 trillion between 2011-2025, yet less than 2% of global health funding targets these conditions. This gap between disease burden and resource allocation represents one of the most significant blind spots in global health policy today. And solving it requires political will to reimagine how we fund, structure, and sustain care for chronic conditions in LMICs. FINANCING: THE POLITICAL FAULT LINE Despite the scale of the NCD crisis, global health financing remains misaligned. Traditional approaches to healthcare financing in LMICs have proven insufficient for the chronic, long-term nature of NCDs. Infectious disease programs benefit from vertical funding mechanisms with clear endpoints, while NCDs require sustained investment in health systems strengthening, continuous medication access, Jon Fairest, head of Global Health Unit, Sanofi
58
Health: A Political Choice – The Future of Health in a Fractured World
Made with FlippingBook Annual report maker